About | Free Trial

Last Update

2016-05-17T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Richard Chipkin?

Dr. Richard Chipkin E.

President and Chief Executive Officer

Psyadon Pharmaceuticals , Inc.

HQ Phone: (301) 919-2020

Psyadon Pharmaceuticals , Inc.

20451 Seneca Meadows Parkway

Germantown, Maryland 20876

United States

Company Description

Psyadon Pharmaceuticals is dedicated to the discovery and development of new treatments for the serious psychiatric and neurological diseases. Ecopipam, our first development candidate, selectively blocks the actions of the neurotransmitter dopamine at th... more

Background Information

Affiliations

Board Member
Tech Council of Maryland

Board Member
Technology Vision Group LLC

Education

Ph.D.
Pharmacology
Medical College of Virginia

undergraduate degree
Pharmacology
State University of New York at Albany

Web References (121 Total References)


Board of Directors | Tech Council of Maryland

www.techcouncilmd.com [cached]

Richard E. Chipkin, Ph.D. President and Chief Executive Officer Psyadon Pharmaceuticals


Psyadon Pharmaceuticals Home Page

www.psyadonrx.com [cached]

Dr. Richard E. Chipkin, PhD, President and CEO

Dr. Chipkin has more than 20 years experience at both biotech and big pharmaceutical companies. Most recently, he was President and CEO of Psychiatric Genomics. While there, he raised two rounds of venture capital financing, re-organized the company, and negotiated multiple academic licenses. Prior to that, he worked at Schering-Plough Corporation in the Global Business Development Group, where he was responsible for licensing and acquisition in multiple therapeutic areas. In this capacity, Dr. Chipkin negotiated several multi-million dollar research & development and development/marketing deals, including the license for INTEGRILIN®, currently a $250M/year product. Earlier in his career at Schering-Plough, he held positions in both preclinical and clinical neuropharmacology research. Among his accomplishments in the research arena were the discovery of novel analgesic and antipsychotic drugs, including the identification and human testing of ecopipam -- the world's first selective D1 antagonist. Dr. Chipkin received his undergraduate degree from the State University of New York at Albany and his PhD in Pharmacology from the Medical College of Virginia. He did post-doctoral work at the University of Colorado Medical Center.


Richard Chipkin, President ...

www.orphan-drugs.org [cached]

Richard Chipkin, President and CEO of Psyadon, stated, "We are honored to be selected as the first company the TSA has collaborated with on a clinical drug study.


Tourette Syndrome Research | Greater Missouri TSA

missouritsa.org [cached]

Richard Chipkin, President and CEO of Psyadon, said: "We are honored to be selected as the first company the TSA has collaborated with on a clinical drug study.


Paragon Bioservices CEO Elected to the MdBio Division Board of Directors

www.paragonbioservices.com [cached]

• Richard E. Chipkin, Ph.D., President and CEO, Psyadon Pharmaceuticals

Similar Profiles

Other People with this Name

Other people with the name Chipkin

Paul Chipkin
Staten Island Peer Advocacy

Rebecca Chipkin
Diller Scofidio + Renfro

Alice Chipkin
The Stella Prize

Roy Chipkin
CB Richard Ellis Inc

Stephen Chipkin
Weizmann Australia

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory